Ardelyx (ARDX) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.58% |
| Dec 31, 2025 | 3.17% |
| Sep 30, 2025 | 4.16% |
| Jun 30, 2025 | 13.79% |
| Mar 31, 2025 | -5.87% |
| Dec 31, 2024 | 18.46% |
| Sep 30, 2024 | 7.10% |
| Jun 30, 2024 | 0.32% |
| Mar 31, 2024 | 15.06% |
| Dec 31, 2023 | 2.83% |
| Sep 30, 2023 | 37.01% |
| Jun 30, 2023 | -2.68% |
| Mar 31, 2023 | 14.18% |
| Dec 31, 2022 | 31.38% |
| Sep 30, 2022 | 9.92% |
| Jun 30, 2022 | 1.70% |
| Mar 31, 2022 | -13.68% |
| Dec 31, 2021 | -12.25% |
| Sep 30, 2021 | -16.65% |
| Jun 30, 2021 | -2.53% |
| Mar 31, 2021 | 4.33% |
| Dec 31, 2020 | 1.51% |
| Sep 30, 2020 | -8.64% |
| Jun 30, 2020 | -7.64% |
| Mar 31, 2020 | -9.42% |
| Dec 31, 2019 | 117.55% |
| Sep 30, 2019 | -13.46% |
| Jun 30, 2019 | -16.95% |
| Mar 31, 2019 | -9.38% |
| Dec 31, 2018 | -11.29% |
| Sep 30, 2018 | -9.57% |
| Jun 30, 2018 | 60.00% |
| Mar 31, 2018 | -9.54% |
| Dec 31, 2017 | 10.34% |
| Sep 30, 2017 | -12.81% |
| Jun 30, 2017 | -12.59% |
| Mar 31, 2017 | -11.90% |
| Dec 31, 2016 | -11.68% |
| Sep 30, 2016 | 55.31% |
| Jun 30, 2016 | -13.92% |
| Mar 31, 2016 | 54.34% |
| Dec 31, 2015 | -15.30% |
| Sep 30, 2015 | -6.83% |
| Jun 30, 2015 | 40.60% |
| Mar 31, 2015 | -7.07% |
| Dec 31, 2014 | -3.67% |
| Sep 30, 2014 | -4.66% |